Entering text into the input field will update the search result below

Prometheus gets $10M milestone payment under Dr. Falk Pharma collaboration agreement

Jun. 21, 2021 9:16 AM ETMerck & Co., Inc. (MRK) StockBy: SA News Team
  • Prometheus Biosciences (NASDAQ:RXDX) has received a $10M milestone payment from Dr. Falk Pharma GmbH under its collaboration agreement to develop and commercialize the company's second program, PR600.
  • Prometheus has selected a clinical candidate for PR600, targeting an undisclosed member of the

Recommended For You

More Trending News

About MRK Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MRK--
Merck & Co., Inc.